Login / Signup

Patiromer and Spironolactone in Resistant Hypertension and Advanced CKD: Analysis of the Randomized AMBER Trial.

Rajiv AgarwalPatrick RossignolJeffrey BuddenMartha R MayoSusan ArthurBryan WilliamsWilliam B White
Published in: Kidney360 (2021)
Clinicaltrials.gov, NCT03071263.
Keyphrases
  • phase iii
  • phase ii
  • open label
  • double blind
  • blood pressure
  • clinical trial
  • placebo controlled
  • chronic kidney disease
  • study protocol
  • randomized controlled trial
  • arterial hypertension